Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21330,189,0.98 [0.82-1.16],0.7763575127006995
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22508,239,0.94 [0.81-1.09],0.4289468924824234
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22231,1714,1.04 [0.98-1.10],0.2025860605276097
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Candidiasis,22515,533,1.03 [0.93-1.14],0.547668780370221
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21766,4121,1.03 [0.99-1.06],0.1631719711553179
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21725,4220,1.02 [0.98-1.06],0.3117723743718276
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22235,1399,1.01 [0.95-1.08],0.6413452799671017
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,22422,124,0.92 [0.75-1.14],0.4665469306996633
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,19740,1262,1.01 [0.95-1.08],0.7215844970652147
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19072,1554,1.01 [0.96-1.08],0.6249234158592587
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,18561,330,1.03 [0.91-1.17],0.5978447943265447
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14659,2690,1.00 [0.96-1.05],0.8385014593720422
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18507,483,1.07 [0.97-1.19],0.1873691449042417
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22489,1653,0.99 [0.94-1.05],0.7739381427123261
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Mycoses,22603,621,1.05 [0.96-1.15],0.2826131379069265
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,21734,1217,1.02 [0.96-1.09],0.4975814668782533
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22532,1391,1.00 [0.94-1.06],0.9933161725803602
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21075,239,0.94 [0.81-1.09],0.4292552207414282
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,22662,66,1.10 [0.83-1.45],0.5138150127409329
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22358,1217,1.01 [0.94-1.08],0.8173747740636021
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22374,76,1.15 [0.89-1.48],0.2995667151325328
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other viral diseases,22598,136,1.12 [0.93-1.36],0.2391473350944823
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",22577,115,1.12 [0.91-1.38],0.2989864577322693
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21007,490,1.08 [0.98-1.20],0.1321282432256089
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,20817,300,1.01 [0.89-1.16],0.8320861621791249
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,20968,132,1.02 [0.84-1.25],0.8323470113130278
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,22647,46,0.97 [0.68-1.36],0.8432642101592911
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,22597,165,1.00 [0.83-1.20],0.977034642962086
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral warts,22486,54,1.26 [0.93-1.69],0.1355595370682282
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],22504,72,0.81 [0.61-1.08],0.1440937679275185
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm,22374,259,0.83 [0.71-0.97],0.0157703304000069
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,22579,39,0.89 [0.61-1.29],0.5276783792029083
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,22564,43,0.94 [0.66-1.34],0.7352518110322115
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10805,83,0.80 [0.61-1.05],0.1150193566650611
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22205,1628,1.02 [0.96-1.08],0.5249337340804081
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of meninges,22647,65,1.19 [0.90-1.56],0.2218065520779489
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,22571,77,0.98 [0.75-1.28],0.8904395095681468
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,22634,115,0.96 [0.77-1.19],0.6866694445332417
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of ovary,11789,73,1.04 [0.80-1.35],0.7714509580162444
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Ascending colon,22622,428,1.00 [0.90-1.12],0.9644258681015512
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Caecum,22628,382,0.98 [0.87-1.10],0.7078689307720614
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",22515,82,0.87 [0.67-1.13],0.2990346315660924
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Descending colon,22620,248,1.05 [0.91-1.21],0.5180251027644024
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Rectum,22581,394,0.97 [0.86-1.09],0.6230243574931809
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22511,658,1.03 [0.94-1.12],0.5739941143780001
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Transverse colon,22606,528,1.03 [0.93-1.14],0.5842387265027942
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Carcinoma in situ of breast,8869,47,0.78 [0.55-1.11],0.1684640991484131
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",8912,64,1.08 [0.82-1.44],0.5719274620320842
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16187,69,0.82 [0.62-1.10],0.193839871153635
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16215,97,0.95 [0.75-1.21],0.685940094723426
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",22605,121,0.89 [0.71-1.10],0.2708609251505446
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma, any site",22606,119,0.90 [0.72-1.12],0.3284406664545533
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Leiomyoma of uterus,11526,160,1.01 [0.84-1.21],0.9405170717113764
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Lung cancer and mesothelioma,14342,471,1.05 [0.95-1.16],0.3599955137400247
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Lymphoid leukaemia,16189,71,0.86 [0.64-1.14],0.2847212149801984
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16339,221,1.06 [0.91-1.24],0.4558169500296476
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16426,308,0.94 [0.82-1.07],0.3531930487196416
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",8987,101,0.89 [0.71-1.13],0.346914880076676
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16222,104,1.10 [0.88-1.38],0.3875603736790382
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16261,143,1.06 [0.88-1.29],0.5289048305133173
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16237,119,0.93 [0.75-1.16],0.5321183303546482
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",8972,86,0.94 [0.74-1.21],0.649218744725232
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16242,124,0.96 [0.78-1.18],0.6807560421589183
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8180,948,0.95 [0.88-1.03],0.223829850465654
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16250,132,0.95 [0.77-1.16],0.6041564630922978
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16206,88,1.18 [0.94-1.50],0.1584105340911839
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16261,143,1.09 [0.90-1.32],0.3564061274025077
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi,22521,181,0.96 [0.81-1.14],0.6584244092710664
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi of trunk,22635,76,1.12 [0.87-1.46],0.375438309487963
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanoma in situ,16170,109,1.04 [0.83-1.30],0.7284618943431693
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16236,118,0.91 [0.74-1.14],0.4221210091970676
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16314,196,1.00 [0.84-1.18],0.962225848354657
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16439,321,0.97 [0.85-1.10],0.6375849586464282
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16241,123,1.13 [0.92-1.38],0.2488935918286228
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Other benign neoplasms of skin,22488,158,0.92 [0.76-1.11],0.378894846241863
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17568,1450,0.98 [0.92-1.04],0.5153378518512082
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",17651,1533,0.99 [0.93-1.05],0.6880205355473454
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22368,381,0.95 [0.84-1.07],0.3837004805086595
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20383,161,0.95 [0.79-1.15],0.6094876571134853
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22054,67,1.08 [0.81-1.42],0.6043534618754058
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21912,3423,1.02 [0.98-1.06],0.4103117693372704
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,20975,72,1.07 [0.82-1.40],0.5959641672176802
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22196,64,1.07 [0.80-1.42],0.6610777038445372
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22155,1933,1.01 [0.96-1.06],0.7058945218384187
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22154,1932,1.01 [0.96-1.06],0.7452532655539861
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20333,111,0.85 [0.68-1.07],0.1688710021844862
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22308,1405,1.10 [1.03-1.16],0.0029277232629535
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22243,111,0.87 [0.69-1.09],0.2238232677299682
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22057,70,0.84 [0.63-1.13],0.249349206339308
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22060,73,1.05 [0.80-1.37],0.7278667837980086
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,22483,351,0.78 [0.68-0.89],0.0002026965879904
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,22534,38,0.94 [0.64-1.38],0.7616857916610367
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22420,288,0.67 [0.57-0.77],1.0127798749322365e-07
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21033,130,1.07 [0.87-1.30],0.5306484999835177
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15140,408,0.96 [0.86-1.08],0.5384950816546783
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21187,97,1.04 [0.82-1.33],0.721034110610158
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21198,108,0.97 [0.78-1.22],0.811544229767335
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14802,70,1.01 [0.77-1.34],0.9329987957806491
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21052,63,0.91 [0.67-1.22],0.5106953840206745
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20286,313,0.94 [0.83-1.08],0.3939169977404307
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",21875,950,0.99 [0.92-1.07],0.7636004846491768
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,21403,478,0.96 [0.86-1.07],0.4561266203410467
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21143,218,1.22 [1.05-1.42],0.0086796498666179
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22380,1391,1.08 [1.02-1.15],0.0138407303488677
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19051,1347,1.09 [1.02-1.16],0.0078262281453769
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14823,91,0.76 [0.58-0.98],0.0341844593960956
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20409,97,1.05 [0.83-1.32],0.7066971796956225
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15093,361,1.01 [0.89-1.14],0.9191998479666432
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14785,53,1.14 [0.83-1.55],0.4232681217924804
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19244,4512,1.03 [1.00-1.07],0.075350551099245
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,14988,256,1.00 [0.86-1.15],0.9669802275848348
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15427,695,1.02 [0.93-1.11],0.6489195312138396
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,22601,359,0.98 [0.87-1.11],0.7288760105951089
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22395,153,0.91 [0.75-1.10],0.3114925213986639
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,14884,152,1.01 [0.84-1.22],0.888188791921878
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14809,77,0.96 [0.74-1.26],0.7840439907054483
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22034,1722,0.96 [0.91-1.01],0.1279431491288396
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15111,379,1.04 [0.92-1.17],0.5380447739072085
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15150,418,0.94 [0.84-1.06],0.3225758836083617
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15581,849,1.11 [1.03-1.20],0.0094763727118003
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14907,175,0.85 [0.71-1.03],0.0904643880821583
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22386,144,0.90 [0.74-1.10],0.3200768805115333
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15618,886,1.03 [0.95-1.11],0.507327358686245
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15377,645,1.01 [0.93-1.11],0.7735234601630184
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20053,80,1.01 [0.78-1.31],0.9139530966314556
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21037,6305,1.02 [0.99-1.05],0.1491228817255434
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20371,59,0.96 [0.71-1.29],0.7701996361742964
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20363,51,0.72 [0.51-1.02],0.0644530024335054
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22480,1866,0.95 [0.90-1.01],0.0955275089745652
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22477,1863,0.95 [0.90-1.01],0.1014879842396144
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20377,65,0.93 [0.70-1.24],0.6247717168613245
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22318,1110,1.03 [0.96-1.10],0.454101945445086
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",16937,2205,1.00 [0.95-1.05],0.9723175649860636
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,22646,306,1.01 [0.88-1.15],0.9162244678765606
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21052,127,1.11 [0.91-1.36],0.2930081078905535
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21322,114,0.94 [0.75-1.17],0.5562599616911106
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21365,157,1.25 [1.05-1.49],0.0142976749558409
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",14928,196,1.13 [0.96-1.33],0.1399936183921301
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,19925,179,0.95 [0.79-1.13],0.5522860315164738
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2418,95,0.98 [0.77-1.26],0.8815499359602631
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2583,300,0.98 [0.86-1.13],0.820683231816031
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,19826,80,1.19 [0.92-1.53],0.1907649883429841
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2394,74,0.72 [0.53-0.96],0.0269799647487248
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21834,2088,1.04 [0.99-1.10],0.1168330142615754
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,21551,626,0.91 [0.83-1.00],0.0618130845422235
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,20410,437,1.05 [0.94-1.17],0.4136966528895993
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15827,1095,1.03 [0.96-1.11],0.3839266559067988
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22526,301,0.88 [0.77-1.01],0.0653995468027223
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21208,266,0.88 [0.76-1.02],0.0966490962169055
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Angina pectoris,19556,1541,1.01 [0.95-1.07],0.7281784781984706
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21311,369,0.89 [0.78-1.00],0.0533858239993596
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21027,85,1.10 [0.87-1.41],0.4282856480980375
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21228,286,1.04 [0.91-1.19],0.529599849816264
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11465,2773,0.96 [0.91-1.00],0.0469662631119706
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,AV-block,17206,653,0.99 [0.90-1.08],0.7694974225924605
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22578,569,0.93 [0.84-1.02],0.138387364431204
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cardiac arrest,8953,261,1.12 [0.97-1.29],0.1198287564680102
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cardiomyopathy,16747,194,0.90 [0.75-1.06],0.2071487503359874
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",16658,105,0.99 [0.79-1.24],0.9237066265195965
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,22657,80,1.31 [1.03-1.67],0.0274606671741852
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Conduction disorders,18062,1509,0.98 [0.92-1.04],0.5057138192298178
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20699,2707,1.01 [0.97-1.06],0.5515237569858626
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18173,8702,1.00 [0.98-1.03],0.933242617573913
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21127,331,0.91 [0.80-1.04],0.1693048605817066
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Endocarditis,16655,102,1.14 [0.91-1.43],0.2426867837474068
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22375,1633,1.01 [0.95-1.07],0.8227285884237816
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertension,19386,7755,1.01 [0.98-1.04],0.4091774195377043
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19404,7773,1.01 [0.98-1.04],0.453311831141254
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, portal",22496,89,0.79 [0.61-1.02],0.0716136520145326
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",11884,253,1.07 [0.92-1.24],0.3756857600136306
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,11836,205,1.08 [0.92-1.27],0.3574010715290523
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypotension,22479,1607,1.04 [0.98-1.10],0.1502035565494731
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,21389,148,0.94 [0.78-1.14],0.5349028242567913
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20868,2853,1.02 [0.98-1.07],0.2780348168806346
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22153,781,1.07 [0.98-1.16],0.1241778235420296
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17065,512,1.00 [0.90-1.11],0.9575469003955338
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,21982,1041,1.03 [0.96-1.10],0.4664295446069373
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",18914,899,1.05 [0.98-1.14],0.1806958160653505
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",22535,181,1.21 [1.03-1.42],0.0215967433294404
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",22618,403,0.97 [0.87-1.09],0.6670560495195762
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Oesophageal varices,20857,61,0.88 [0.64-1.19],0.3997218704036196
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other aneurysm,21043,101,0.94 [0.74-1.18],0.5763230475915194
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other arrhythmias,17137,584,1.04 [0.95-1.15],0.3679752821061012
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21075,133,1.11 [0.91-1.34],0.2953500624596018
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21264,322,0.98 [0.86-1.12],0.7707454510325296
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,16773,220,0.97 [0.83-1.14],0.7384346116578285
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other disorders of veins,20914,118,0.97 [0.78-1.20],0.7783073199174324
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,20841,45,0.98 [0.69-1.38],0.8936581148712303
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,20639,88,1.00 [0.78-1.28],0.9881595220371302
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,20970,174,1.03 [0.86-1.22],0.7807366025486194
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,17984,1431,0.94 [0.88-1.00],0.041628687864169
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,20933,61,0.80 [0.59-1.09],0.1636799757665547
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21655,713,1.00 [0.92-1.09],0.9893666995051524
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,21903,514,1.01 [0.91-1.12],0.8040690570148553
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",21508,957,1.03 [0.95-1.10],0.513541112919681
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9103,411,0.96 [0.86-1.08],0.5376619383715021
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21488,578,1.00 [0.91-1.10],0.9669969730362944
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21213,417,0.92 [0.82-1.03],0.1664023663262928
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Pulmonary embolism,21975,586,0.93 [0.84-1.02],0.1316048996682861
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22563,950,0.97 [0.90-1.05],0.431199664522739
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17057,504,0.98 [0.88-1.09],0.7372670811117532
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Secondary right heart disease,21898,509,1.02 [0.92-1.13],0.7298485471011292
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,20812,261,0.99 [0.86-1.15],0.930684829809848
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22137,896,1.05 [0.98-1.14],0.1760361668560263
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22122,935,1.05 [0.98-1.14],0.1758864635736237
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,21361,62,1.00 [0.75-1.34],0.9941523431316338
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21046,104,0.78 [0.62-1.00],0.0470686542143878
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Transient ischemic attack,21691,319,1.03 [0.91-1.17],0.642828405500764
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21264,323,1.02 [0.90-1.16],0.7555278715243872
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Varicose veins,21303,507,1.05 [0.95-1.16],0.3833280272767441
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,20961,121,0.85 [0.68-1.05],0.1354162251975641
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22386,926,0.92 [0.85-0.99],0.0365649536653263
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22580,319,1.02 [0.90-1.16],0.7683616799601762
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19350,1352,1.04 [0.98-1.11],0.2353906368646616
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Any mental disorder,22136,4138,1.02 [0.99-1.06],0.1739973441767791
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22552,376,1.00 [0.89-1.12],0.9802581414224656
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19416,1418,1.09 [1.02-1.15],0.0069319017228139
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18081,83,1.23 [0.97-1.57],0.0885262225316527
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Smoking dependency,22158,1154,1.05 [0.98-1.11],0.169718213362259
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19413,1415,1.03 [0.97-1.09],0.3291466340481349
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Vascular dementia,21767,229,0.88 [0.76-1.04],0.1275414550945554
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Alzheimer disease,22659,584,0.98 [0.89-1.08],0.7474724363088625
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",13879,109,1.08 [0.86-1.34],0.5166692412971752
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Bell's palsy,20850,83,0.94 [0.72-1.21],0.6163601263946765
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21245,478,0.98 [0.88-1.09],0.7117460350438949
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Cerebral cysts,22225,245,1.02 [0.88-1.18],0.7808218602803633
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22586,403,0.97 [0.86-1.09],0.5799116566906286
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,21816,73,1.23 [0.95-1.60],0.1131862696576301
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,22642,67,0.90 [0.67-1.21],0.4957543860743757
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22064,84,1.10 [0.86-1.41],0.4592509857050193
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Epilepsy,21181,298,0.97 [0.84-1.11],0.6249985900674113
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22205,1322,1.01 [0.95-1.07],0.8034742004460486
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,22605,914,1.02 [0.95-1.10],0.5690529125602253
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22012,3401,1.00 [0.96-1.04],0.9983332361742296
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Generalized epilepsy,22292,54,1.25 [0.93-1.68],0.1452068064716914
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Hemiplegia,22510,327,1.05 [0.93-1.20],0.4115730098226032
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Hydrocephalus,22056,76,0.92 [0.70-1.20],0.5427685392406578
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,22645,69,1.15 [0.88-1.50],0.3125428748233994
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,20833,66,0.82 [0.61-1.10],0.1925419335339431
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,20837,70,0.88 [0.66-1.17],0.3796973243250603
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Memory loss,21519,141,0.92 [0.75-1.13],0.422492588258156
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Migraine,21155,272,0.97 [0.84-1.12],0.6756341567467742
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",22613,249,0.97 [0.84-1.13],0.7241059086028685
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Motor neuron disease,13961,168,1.06 [0.89-1.27],0.4996046772392143
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,22531,58,1.03 [0.77-1.39],0.8401546543137061
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",21960,1193,0.98 [0.92-1.05],0.6317040777161205
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Neurological diseases,21205,4275,1.00 [0.97-1.04],0.8897269996636722
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22066,323,1.07 [0.94-1.21],0.3252416256309841
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21183,416,1.11 [0.99-1.23],0.0773109061033823
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",22583,337,1.04 [0.92-1.18],0.5507166018722851
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16949,964,1.05 [0.97-1.13],0.2198193561874648
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22064,84,0.90 [0.70-1.17],0.4481533111457462
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22140,160,0.86 [0.71-1.04],0.1278787958041158
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,21924,233,1.05 [0.90-1.22],0.5280456080735088
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other facial nerve disorders,20860,93,0.93 [0.73-1.19],0.566375272443528
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other headache syndromes,20933,50,0.99 [0.71-1.37],0.9494465111954444
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other neurological diseases,22551,571,1.00 [0.90-1.10],0.9364777121257016
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other sleep disorders,21391,508,1.04 [0.94-1.16],0.4383364501827967
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Parkinson's disease,22626,677,1.02 [0.93-1.11],0.6904354286194996
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22025,45,1.07 [0.77-1.51],0.6794091539606296
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Restless leg syndrome,22659,109,1.04 [0.84-1.29],0.7202506829653057
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Sleep apnoea,22427,431,1.06 [0.94-1.18],0.3512457451157487
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22303,57,1.00 [0.74-1.37],0.9821528044657972
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,22648,194,1.04 [0.88-1.23],0.6314733433804176
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,20833,66,0.85 [0.64-1.15],0.2916643871317834
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,22659,590,0.98 [0.89-1.08],0.6726813180763557
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),21708,223,0.89 [0.76-1.04],0.1393666827156152
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22029,151,1.06 [0.88-1.27],0.5567448383637501
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22214,555,1.02 [0.92-1.12],0.7099867178610793
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22407,262,0.95 [0.82-1.10],0.4923375688327438
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,21454,66,1.00 [0.75-1.33],0.9795535368057932
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21427,39,1.33 [0.94-1.88],0.1116694730744155
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",22538,65,1.14 [0.86-1.50],0.3669674517193524
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22348,221,1.01 [0.87-1.18],0.8639165239161859
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2398,75,0.68 [0.50-0.91],0.009960061669943
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2961,110,0.97 [0.78-1.22],0.8229293470567525
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,21980,102,1.15 [0.93-1.44],0.2024679504891413
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22367,1408,1.04 [0.98-1.10],0.2294369908196881
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22254,866,1.04 [0.96-1.12],0.3217266273044192
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,21690,302,1.18 [1.04-1.34],0.0124385576168868
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22586,927,1.02 [0.95-1.10],0.5322432729739148
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,22652,82,1.44 [1.14-1.82],0.0020117201227626
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,22515,856,1.03 [0.95-1.11],0.529345561302364
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",22619,492,0.98 [0.89-1.09],0.7709204694747608
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,22541,221,1.13 [0.97-1.32],0.1052829448073608
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,21484,96,1.02 [0.80-1.29],0.8832209108197097
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,21487,99,1.01 [0.80-1.27],0.9432124411712134
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,21465,77,1.12 [0.87-1.45],0.3841664839343419
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22529,989,1.02 [0.94-1.09],0.6894737511735536
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,21798,258,1.00 [0.87-1.16],0.9511917748087508
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,21729,70,0.85 [0.64-1.13],0.2709377517163581
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22247,120,0.82 [0.66-1.02],0.072083091256161
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,22511,384,1.03 [0.91-1.15],0.6521022467220126
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,21873,214,1.07 [0.92-1.25],0.377495392712883
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,22459,139,1.03 [0.85-1.25],0.7714126094381348
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22202,662,1.05 [0.96-1.14],0.3311684032386013
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22038,160,0.96 [0.80-1.16],0.6891801942448028
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20242,3158,1.03 [0.99-1.07],0.1953058953833688
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,22467,340,1.02 [0.90-1.16],0.748564387632604
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,22646,184,1.08 [0.91-1.28],0.3696618268775319
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,21913,525,0.96 [0.87-1.07],0.4507485269611089
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22216,89,0.81 [0.62-1.04],0.1013030903590017
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,22643,73,1.42 [1.11-1.81],0.0055322170752966
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,21512,124,0.87 [0.70-1.08],0.1974056673778932
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,21559,171,0.87 [0.73-1.05],0.1423440225599408
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21122,163,1.25 [1.06-1.49],0.0099063494966095
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,21721,62,0.87 [0.65-1.18],0.386438059490633
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21028,69,0.79 [0.59-1.06],0.1099757505041853
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,21651,111,0.85 [0.68-1.07],0.1628808047331577
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",21826,286,1.00 [0.87-1.14],0.9482334175417334
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,21544,156,0.98 [0.81-1.18],0.8024102134400946
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21051,92,1.26 [1.00-1.58],0.0458396132902879
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21087,128,1.01 [0.82-1.24],0.9418840757479476
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,19772,2688,1.02 [0.97-1.06],0.4788409200974856
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,21480,92,1.18 [0.94-1.49],0.1611309075833393
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22371,493,1.08 [0.97-1.19],0.1589202975178942
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,21953,75,1.18 [0.91-1.51],0.2084630790630146
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22080,202,1.14 [0.98-1.34],0.0912630860612917
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,22442,109,1.03 [0.83-1.28],0.8013716634921928
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,22611,137,0.98 [0.80-1.19],0.830567917489784
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,22524,111,1.20 [0.98-1.48],0.0802334719116799
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,22394,61,1.05 [0.78-1.40],0.7528835146105137
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,22398,65,0.94 [0.70-1.26],0.6680905577899159
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,22551,1216,0.97 [0.91-1.04],0.4007143847513835
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22258,923,0.98 [0.91-1.06],0.6844049318539522
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,21484,149,0.80 [0.66-0.98],0.0315651478484797
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,21421,86,0.97 [0.76-1.25],0.8279028564579273
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute pharyngitis,22473,63,0.91 [0.68-1.23],0.5541558565691571
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,22587,177,0.92 [0.77-1.10],0.3621354779743467
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,22471,61,0.96 [0.71-1.29],0.7653958893273237
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,All influenza,20036,154,0.92 [0.76-1.11],0.401834880393753
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20033,151,0.94 [0.78-1.14],0.5305535185046206
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Allergic asthma (mode),13973,102,1.18 [0.95-1.47],0.1436091669384277
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Allergic rhinitis,22554,232,0.99 [0.85-1.15],0.9004827175793624
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15159,1671,1.05 [0.99-1.11],0.109563766726933
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15520,1649,1.05 [0.99-1.11],0.1257192445436928
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22155,174,0.99 [0.83-1.18],0.879176535718273
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",19985,103,1.02 [0.81-1.28],0.845966333960684
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Bronchiectasis,19014,506,1.07 [0.97-1.19],0.1697822870896212
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",18578,70,1.33 [1.04-1.71],0.0241167058148514
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21560,3052,1.05 [1.01-1.09],0.0219318187351737
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21450,70,0.86 [0.64-1.14],0.2978186379393422
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic sinusitis,21513,133,1.08 [0.89-1.32],0.4253423738209876
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22375,1595,1.05 [0.99-1.11],0.1150355864418875
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Deviated nasal septum,21462,82,0.98 [0.76-1.27],0.8988831509902898
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20553,5981,1.04 [1.01-1.07],0.0076592041795741
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",21714,334,1.01 [0.89-1.15],0.8695854424861598
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Early onset COPD,20887,107,1.09 [0.88-1.35],0.4167029264817978
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Emphysema,18929,421,1.17 [1.05-1.29],0.0035519511800979
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21401,438,1.06 [0.95-1.18],0.2744779800817318
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22407,2525,1.04 [0.99-1.09],0.0951842224517907
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Interstitial lung disease,21442,479,1.07 [0.97-1.19],0.1728504622877145
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Later onset COPD,22152,1488,1.04 [0.98-1.11],0.1545891260732282
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,22643,482,1.06 [0.95-1.17],0.3037695019079856
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Nasal polyp,21474,94,0.94 [0.74-1.20],0.6319193845844278
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22378,1262,1.03 [0.96-1.09],0.4341110760694567
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of pleura,22376,2627,1.03 [0.99-1.08],0.189311160304674
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22118,738,1.03 [0.95-1.12],0.5043276827218655
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other pleural conditions,19817,68,0.97 [0.73-1.28],0.8156915474563533
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22542,573,1.09 [0.99-1.20],0.0730523209463763
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22535,1680,1.04 [0.99-1.10],0.1450951746160315
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pleural effusion,21087,1338,1.02 [0.96-1.09],0.5170884656643973
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pleural plaque,19995,246,0.98 [0.85-1.14],0.8051678369029454
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22124,2242,1.05 [1.00-1.10],0.0525889887809144
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,22538,377,1.04 [0.92-1.17],0.5670310551684894
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pneumothorax,19912,163,0.87 [0.73-1.05],0.159119002038462
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pollen allergy,22648,197,1.08 [0.92-1.27],0.3543226913228011
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pulmonary oedema,22060,91,1.12 [0.89-1.42],0.3286323717506135
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Respiratory insufficiency,13940,69,1.27 [0.98-1.65],0.0673826068282826
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22356,1240,1.03 [0.96-1.10],0.3979205651558277
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,21614,234,1.00 [0.86-1.16],0.9693652961539012
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Viral pneumonia,20175,293,0.99 [0.86-1.13],0.8559312926785443
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22164,236,0.99 [0.86-1.16],0.945865188188598
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7224,115,1.01 [0.81-1.26],0.8972174991003475
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14349,61,1.20 [0.91-1.60],0.1993648166228244
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute appendicitis,22546,126,1.09 [0.89-1.33],0.3948189562705972
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute gastritis,15765,106,1.14 [0.91-1.41],0.2497152754772775
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute pancreatitis,20665,188,1.06 [0.89-1.25],0.5280813682993919
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute peritonitis,22179,108,1.06 [0.85-1.32],0.5835472765042631
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Alcoholic liver disease,21710,62,0.91 [0.67-1.23],0.5382207674195929
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Barrett oesophagus,16153,494,0.95 [0.86-1.06],0.3840555379274396
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",20619,142,1.00 [0.82-1.22],0.9956690375965114
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22249,142,0.99 [0.82-1.21],0.9428851790467524
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholecystitis,20689,212,0.99 [0.84-1.16],0.8830508301537707
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholelithiasis,21495,1018,1.07 [0.99-1.15],0.0790332330947275
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Chronic gastritis,15999,340,1.03 [0.91-1.17],0.626195712034362
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Chronic pancreatitis,20530,53,0.95 [0.69-1.31],0.7718874089762727
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",22526,119,0.87 [0.70-1.08],0.2133126852468579
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Coeliac disease,20954,123,1.16 [0.95-1.42],0.1435514025204091
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Collagenous colitis,20952,102,0.92 [0.73-1.16],0.4813597892514386
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,22543,154,0.93 [0.77-1.12],0.4560224855752133
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Constipation,22382,2089,0.96 [0.92-1.01],0.1641665542194786
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn disease,20936,86,1.16 [0.91-1.47],0.2327410869712061
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22316,65,1.08 [0.82-1.43],0.5935674103709718
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn's disease NAS,20929,79,1.18 [0.92-1.51],0.188016616159962
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Dental caries,22067,187,1.16 [0.98-1.36],0.083376909444792
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19592,2510,1.02 [0.98-1.07],0.3350232702847459
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of appendix,22576,156,1.03 [0.86-1.24],0.7242716469997472
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of liver,22540,892,0.98 [0.90-1.06],0.553521321232801
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20149,4490,1.01 [0.97-1.04],0.6458193223341733
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22340,460,1.04 [0.94-1.16],0.4369189422398112
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22570,499,1.00 [0.90-1.11],0.9528634046645814
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,21972,92,1.01 [0.79-1.28],0.9549545895084264
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of salivary glands,21846,59,1.06 [0.79-1.42],0.7052366018538595
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22334,1503,0.99 [0.93-1.05],0.673693186609774
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of tongue,21862,92,0.89 [0.70-1.14],0.3579345956674196
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",21952,1475,1.07 [1.01-1.14],0.020880553045693
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,17984,3696,1.00 [0.96-1.03],0.8412160119393538
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Duodenal ulcer,15903,244,1.05 [0.91-1.22],0.4932005442834837
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",22565,198,1.02 [0.86-1.20],0.8236882387775142
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,22623,26,1.34 [0.88-2.05],0.1711541725367455
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,21788,140,0.91 [0.74-1.11],0.3651351697424905
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14395,107,0.98 [0.79-1.23],0.890177278100769
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Functional dyspepsia,16211,552,1.05 [0.95-1.16],0.3394971551099907
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastric ulcer,16081,422,1.07 [0.95-1.19],0.263026510294212
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18261,2602,0.99 [0.94-1.03],0.5974648558743975
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16302,643,1.06 [0.96-1.16],0.2432105176578806
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16356,8043,1.00 [0.98-1.03],0.8194756416244777
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,GI-bleeding,22084,1253,0.98 [0.92-1.05],0.6137703816617195
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,21925,45,0.79 [0.55-1.14],0.2164635021801889
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15264,1165,0.96 [0.89-1.02],0.1952665819610839
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",21714,66,0.80 [0.60-1.08],0.1536417305076562
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Hernia,20649,3567,1.01 [0.97-1.05],0.6915690313892822
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Impacted teeth,22627,24,1.45 [0.94-2.24],0.0900442808088771
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Impaction of intestines,14365,77,0.96 [0.74-1.26],0.7736048689489708
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Inguinal hernia,18156,1074,0.99 [0.93-1.07],0.853929034452383
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17203,121,0.92 [0.74-1.15],0.483258160452244
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14403,115,1.05 [0.85-1.30],0.6620649063254362
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal malabsorption,20970,139,1.12 [0.92-1.35],0.2480455015664062
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14789,501,1.03 [0.93-1.14],0.5614630597629369
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,22626,329,1.09 [0.96-1.24],0.1800481036114712
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,21623,773,1.05 [0.97-1.14],0.2406743347615301
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,21919,1069,1.03 [0.96-1.11],0.394111496415872
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15871,212,0.96 [0.81-1.12],0.5965256584014227
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophagitis,16341,682,0.99 [0.91-1.09],0.8993826215131503
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,22605,133,1.16 [0.96-1.40],0.1310198172637671
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17169,87,1.13 [0.89-1.44],0.3195267586506329
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15645,1357,1.03 [0.96-1.09],0.410538754905471
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,20831,354,1.09 [0.96-1.22],0.1785902415516123
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,20619,142,1.14 [0.95-1.38],0.1558581786242213
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestine,16178,1890,0.99 [0.94-1.04],0.6954814005179455
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestines,20385,6097,0.98 [0.95-1.01],0.1126265566877417
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,21826,208,1.16 [1.00-1.35],0.0569692290950296
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of liver,22384,736,0.98 [0.90-1.07],0.6624321324618818
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16407,748,0.98 [0.90-1.07],0.6375402104650982
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of pancreas,20688,211,0.96 [0.82-1.13],0.6131891377283265
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22494,423,0.98 [0.88-1.10],0.7262878367059331
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16732,1073,0.97 [0.91-1.05],0.4723767481487251
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22100,1269,0.98 [0.92-1.05],0.6005891840444385
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22051,171,1.01 [0.85-1.21],0.9028921474046284
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16423,2135,0.96 [0.92-1.01],0.142082049358537
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),17788,2129,1.02 [0.97-1.07],0.5212720834332022
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,21758,110,0.86 [0.69-1.08],0.2011697395223532
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,21796,946,1.02 [0.95-1.10],0.5223021423985572
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14725,437,0.91 [0.81-1.02],0.1123294125815817
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,22619,29,1.30 [0.87-1.95],0.1995297002778405
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14896,608,0.93 [0.85-1.02],0.1389561750575884
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",20982,151,1.03 [0.86-1.25],0.7258843731465442
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Recurring oral aphthae,22647,52,0.73 [0.52-1.03],0.0751042790272985
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,21872,99,1.05 [0.83-1.31],0.6958154812546657
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Toxic colitis,20926,76,0.88 [0.67-1.16],0.3673346435704393
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15991,332,1.11 [0.98-1.26],0.0965808437330241
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcerative colitis,21013,163,1.06 [0.89-1.27],0.5088903166207419
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",20979,129,0.98 [0.80-1.20],0.8479020423475323
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Umbilical hernia,17329,247,0.94 [0.81-1.09],0.4337633219399716
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14529,241,0.90 [0.77-1.05],0.183251703127866
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ventral hernia,17359,277,1.03 [0.89-1.18],0.721463098548669
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Volvulus,14383,95,0.77 [0.60-0.99],0.0436597092283365
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,22555,417,0.92 [0.82-1.03],0.1452401585614393
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22306,63,1.17 [0.88-1.55],0.2783451780501609
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20147,162,1.00 [0.83-1.19],0.9656167039524576
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22035,804,1.02 [0.94-1.10],0.6787246124909242
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21372,141,1.00 [0.82-1.22],0.9918922741921692
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,20603,618,0.96 [0.87-1.05],0.3687166392678181
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22322,312,1.10 [0.97-1.25],0.133417688210731
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22559,549,1.03 [0.93-1.13],0.5801246638535804
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22057,47,0.96 [0.69-1.35],0.8310785762720253
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21083,3657,0.98 [0.94-1.02],0.2919861759508737
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22231,427,0.95 [0.85-1.06],0.373978819349212
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22104,300,0.92 [0.80-1.05],0.2180295944433701
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22277,1046,1.00 [0.93-1.08],0.9150233511133188
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",22640,59,0.78 [0.57-1.07],0.122525294526507
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20041,56,0.84 [0.61-1.15],0.2701375241415975
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,21863,59,1.05 [0.78-1.41],0.7622314587720422
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22309,299,1.09 [0.96-1.25],0.1771730183150434
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20579,594,0.94 [0.85-1.03],0.1791921413912054
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20075,90,0.85 [0.66-1.09],0.195390039035351
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,22571,96,0.87 [0.68-1.12],0.2843485443899433
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21463,232,1.09 [0.93-1.26],0.2807345901750878
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22461,218,1.03 [0.88-1.20],0.7431163507569134
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22103,93,1.08 [0.86-1.37],0.5080984157547872
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20062,77,1.07 [0.83-1.39],0.5958547205619182
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22054,2069,0.98 [0.93-1.03],0.3553290724403464
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",20619,634,0.93 [0.85-1.02],0.1289905674654502
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20078,93,0.81 [0.63-1.04],0.1052430400369672
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,22572,329,1.01 [0.89-1.15],0.864033661830715
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22082,72,0.99 [0.75-1.30],0.9487202514274996
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22512,269,1.07 [0.93-1.22],0.3667478097917137
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22587,449,0.90 [0.80-1.01],0.06335802152319
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20105,120,1.01 [0.82-1.24],0.9445463125527328
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20318,333,0.88 [0.77-1.00],0.052873055149876
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22575,437,0.90 [0.80-1.01],0.0754003553776688
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20313,328,1.04 [0.91-1.18],0.5653155131185575
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,22630,155,0.93 [0.77-1.12],0.4266287994978139
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,18860,77,0.94 [0.71-1.23],0.6279120334374314
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,19975,6310,1.03 [1.00-1.06],0.0869009377095566
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18586,4921,1.03 [0.99-1.06],0.1034278697497376
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,18832,49,0.82 [0.58-1.16],0.2542404716079319
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,18789,144,0.97 [0.80-1.18],0.7550052313999522
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,18834,189,0.99 [0.84-1.18],0.9533207749802038
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22400,65,1.12 [0.85-1.48],0.4357297281515369
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",18792,147,0.90 [0.74-1.09],0.2745782644678004
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15127,1462,1.06 [1.00-1.12],0.0574736604544632
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22452,244,1.09 [0.94-1.26],0.2605196518180118
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19222,577,1.06 [0.96-1.16],0.2671120552116579
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18337,7873,1.02 [0.99-1.05],0.1357920717286222
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20160,116,0.82 [0.65-1.02],0.0763167842668477
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,18965,182,1.05 [0.89-1.24],0.5789211589068488
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19280,497,0.99 [0.89-1.10],0.8416603189653702
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21737,3092,1.02 [0.98-1.07],0.2976926380021205
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19089,306,0.89 [0.78-1.02],0.1013379440877894
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,18929,146,1.14 [0.94-1.37],0.1795388001095818
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,18894,111,1.01 [0.81-1.25],0.9556814464672662
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,21930,95,0.92 [0.72-1.17],0.4786940935044793
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15627,1962,1.04 [0.99-1.09],0.160677924961726
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14438,773,1.03 [0.95-1.12],0.4286985601980666
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22567,767,1.04 [0.96-1.13],0.3648202510927981
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,13740,75,1.15 [0.89-1.49],0.2997344691277329
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),13966,301,1.00 [0.88-1.15],0.9564070758171888
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19046,263,0.95 [0.82-1.10],0.4797044715907912
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14137,472,1.02 [0.91-1.13],0.7580049877479069
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,18725,80,1.29 [1.01-1.65],0.0420489388422013
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19319,674,1.06 [0.97-1.16],0.2078221577440345
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,18956,311,1.14 [1.00-1.29],0.0510369039949996
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14107,442,1.00 [0.89-1.12],0.9706827490458476
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,18854,71,1.18 [0.90-1.54],0.2245433911872509
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",18843,60,1.04 [0.78-1.40],0.7793194899882168
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20126,82,0.91 [0.70-1.19],0.5069108534940294
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22233,2189,0.97 [0.92-1.02],0.1944455904029223
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21583,1539,0.96 [0.90-1.01],0.1309132193220546
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22487,533,1.13 [1.03-1.25],0.0106890029825315
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16730,3065,1.04 [1.00-1.09],0.0372872104277877
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,13707,42,0.97 [0.67-1.39],0.8566512026355824
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,18885,102,1.20 [0.96-1.50],0.1097927658273167
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,13734,69,1.07 [0.81-1.41],0.6567784474753386
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),13800,135,1.05 [0.86-1.28],0.6141776689990228
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20285,241,1.05 [0.91-1.22],0.489771179885123
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,20547,503,1.01 [0.91-1.12],0.9052493642127516
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,22635,111,1.10 [0.89-1.37],0.3740892755147188
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20597,1952,1.01 [0.96-1.06],0.7933321582166661
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,18859,76,1.26 [0.98-1.62],0.0705772360965304
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),13816,151,1.04 [0.87-1.26],0.6538214264863536
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19423,778,1.03 [0.95-1.12],0.4339236695789615
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15806,2141,1.01 [0.96-1.07],0.5979939215223176
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,21955,120,0.95 [0.77-1.17],0.6306960163028807
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,22647,60,1.22 [0.92-1.62],0.1615651610755339
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,18860,77,0.96 [0.74-1.26],0.7823300183810061
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20115,1332,1.08 [1.01-1.15],0.0217859937755086
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,18890,107,1.13 [0.91-1.41],0.2631243563943459
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15705,2040,1.03 [0.98-1.09],0.2062039940821646
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20163,119,1.07 [0.87-1.32],0.506261177981403
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,18819,36,1.08 [0.74-1.58],0.69325953559444
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,18832,187,0.91 [0.77-1.09],0.3074970890809924
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19460,677,1.03 [0.94-1.12],0.5343941647116521
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22313,478,1.07 [0.97-1.19],0.188036411795974
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19299,654,0.98 [0.89-1.07],0.5911352048805283
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22502,528,1.13 [1.03-1.25],0.010766974783943
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,22632,69,1.47 [1.15-1.88],0.0022055735821008
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,18949,166,0.84 [0.70-1.02],0.0727320537502695
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17623,871,1.04 [0.96-1.12],0.3639829289825019
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19417,634,1.08 [0.98-1.18],0.1123339505721206
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19059,276,0.90 [0.78-1.04],0.1667956977007603
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",13734,69,1.06 [0.80-1.39],0.6913944062035859
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16731,3066,1.05 [1.01-1.10],0.0182597685220481
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14490,825,1.04 [0.96-1.13],0.3565432164497311
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22205,370,1.04 [0.93-1.18],0.4844627021306179
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",22604,80,0.98 [0.76-1.27],0.8912267214953233
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20059,70,0.96 [0.72-1.27],0.7797222624975756
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,13726,61,1.21 [0.91-1.61],0.1963196270277241
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,18754,109,1.15 [0.93-1.43],0.1930878655014384
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14205,540,1.14 [1.04-1.26],0.0078058943763533
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19112,329,1.02 [0.90-1.16],0.7692510526224985
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,18925,280,1.14 [1.00-1.30],0.0573388606525455
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,18909,264,1.05 [0.91-1.21],0.4775187889358577
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,15927,67,1.10 [0.83-1.44],0.5112093939002227
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",22637,74,1.36 [1.06-1.73],0.0139335229945064
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19325,542,1.00 [0.90-1.10],0.9538372701743956
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],21924,89,1.20 [0.95-1.51],0.1183453702312239
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21384,2601,1.03 [0.98-1.07],0.2398984246295224
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",18932,149,0.97 [0.80-1.18],0.757693796845551
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19352,707,1.06 [0.97-1.15],0.2219276633666243
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21326,263,0.89 [0.77-1.03],0.1225010922411689
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,18895,250,1.05 [0.90-1.21],0.5460752813528198
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20618,1973,1.03 [0.98-1.09],0.2060009966530238
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,19936,1291,1.07 [1.00-1.14],0.0428453761340448
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],18842,59,1.14 [0.85-1.53],0.3867148998917575
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,21949,114,0.97 [0.78-1.20],0.7478769800093912
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,18943,160,1.14 [0.96-1.36],0.1421636833545616
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,18875,92,0.95 [0.74-1.21],0.6866703133628163
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),13741,76,1.02 [0.78-1.32],0.9104112234379388
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21186,2212,1.00 [0.95-1.05],0.969115884781226
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9058,24,1.39 [0.91-2.14],0.1303337939726483
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11499,34,1.05 [0.71-1.55],0.8103277638112251
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22334,295,1.11 [0.97-1.26],0.1346044618899944
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22138,99,1.01 [0.80-1.28],0.9295543635731532
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21251,2277,0.96 [0.92-1.01],0.1568250971110812
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22430,130,0.97 [0.79-1.19],0.7413670340276018
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22353,398,1.08 [0.96-1.21],0.2120200910663964
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Cystitis,18893,297,1.02 [0.90-1.17],0.7217535660831322
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Dialysis,19068,94,0.91 [0.71-1.17],0.4641079187182649
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9987,2089,1.00 [0.95-1.05],0.969623841314366
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11599,134,1.09 [0.90-1.32],0.3851566506886937
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Endometriosis,9071,37,1.11 [0.77-1.60],0.5809207266149818
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9609,575,1.03 [0.94-1.13],0.5378729171567314
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18656,6150,1.00 [0.97-1.03],0.8494131299776849
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22396,96,0.87 [0.68-1.11],0.2520487672391854
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hydrocele,8010,112,0.87 [0.69-1.10],0.2408128404742027
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19039,340,0.95 [0.83-1.08],0.3916000643426985
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9676,1778,0.99 [0.94-1.05],0.8331282433208176
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11665,156,1.02 [0.85-1.22],0.8544206291915617
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8023,125,0.94 [0.76-1.17],0.5750762357190767
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,18682,86,1.08 [0.84-1.38],0.5430739946407682
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10051,1017,0.99 [0.92-1.06],0.8021656312435337
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,7959,61,0.87 [0.64-1.19],0.3925501471812775
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9072,38,0.94 [0.65-1.38],0.76687958537152
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",22645,86,0.95 [0.74-1.23],0.7184051142894718
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",22647,80,0.84 [0.64-1.10],0.203997082836813
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21488,2892,1.01 [0.96-1.05],0.8046566056616451
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19510,914,0.99 [0.91-1.07],0.7490730411828587
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11516,51,1.02 [0.74-1.40],0.9122064617058536
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22574,619,1.05 [0.96-1.15],0.3082259169322626
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8048,150,1.00 [0.82-1.21],0.977536787690634
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8057,159,1.00 [0.83-1.20],0.9788943986588658
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8043,145,0.89 [0.73-1.09],0.2774327033093251
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,22618,84,0.93 [0.72-1.20],0.5722958361667968
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,20899,2303,1.03 [0.98-1.08],0.3001807782866131
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11589,80,0.99 [0.77-1.28],0.9605860207725712
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9103,69,1.14 [0.87-1.50],0.3283549068357778
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9174,140,0.96 [0.79-1.16],0.6466795420283076
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9083,49,0.78 [0.55-1.10],0.1605408469513882
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9133,99,0.99 [0.79-1.25],0.9539129451536608
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19101,402,0.95 [0.84-1.07],0.3939274207703916
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22154,199,0.98 [0.83-1.15],0.7858846600049949
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9157,123,0.97 [0.79-1.20],0.800485161171038
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9059,25,0.73 [0.45-1.20],0.2128797616136278
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9242,208,1.03 [0.88-1.21],0.6731429247395555
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9124,90,1.06 [0.84-1.34],0.6396185860072792
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9236,202,1.05 [0.89-1.23],0.5836741142393799
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22348,48,0.77 [0.54-1.10],0.1455781975627156
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8051,153,1.01 [0.83-1.22],0.9557706082851822
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22371,3672,0.99 [0.95-1.03],0.5217448168671482
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",18790,91,1.01 [0.79-1.29],0.9486016086547944
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19151,177,0.87 [0.72-1.04],0.1195870667833898
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22074,35,0.82 [0.54-1.24],0.3500721298242661
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urethral stricture,18857,261,0.97 [0.83-1.12],0.6335772162799286
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22415,376,1.07 [0.96-1.21],0.2286721013689478
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9069,35,1.18 [0.80-1.73],0.3955255672647871
